HomeProductsBioactive CompoundsCell CycleDHFRWR99210
Chemical structure of CAS 47326-86-3

WR99210

In Stock•Starting at $103 for 1 mg
CAS No.47326-86-3
MDL No.MFCD01679034
MFC14H18Cl3N5O2
MW394.70
InChI KeyMJZJYWCQPMNPRM-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$103In Stock
5 mgTo Be Confirmed$236In Stock
10 mgTo Be Confirmed$354In Stock
25 mgTo Be Confirmed$620In Stock
50 mgTo Be Confirmed$879In Stock
100 mgTo Be Confirmed$1219In Stock
200 mgTo Be Confirmed$1649In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.47326-86-3
Product NameWR99210
Heavy Atom Count24Rotatable Bond Count6
Atom Stereo Count0Bond Stereo Count0
HBA7HBD2
TPSA98.460 ŲCharge0
Exact Mass393.05261Complexity678.62
pKa7.130XLogP3.028

Related Articles

Studies related to this compound and its mechanism of action

Novel conjugated quinoline-indoles compromise Plasmodium falciparum mitochondrial function and show promising antimalarial activity.

Journal of medicinal chemistry • Vol. 56, Issue 15 • 2013
PMID: 23837878DOI: 10.1021/jm400656s

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Proceedings of the National Academy of Sciences of the United States of America • Vol. 109, Issue 42 • 2012
PMID: 23035243PMC: PMC3479511DOI: 10.1073/pnas.1204556109

Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.

Antimicrobial agents and chemotherapy • Vol. 49, Issue 8 • 2005
PMID: 16048961PMC: PMC1196210DOI: 10.1128/AAC.49.8.3463-3467.2005

The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.

The American journal of tropical medicine and hygiene • Vol. 60, Issue 6 • 1999
PMID: 10403325DOI: 10.4269/ajtmh.1999.60.943

Documentation